header logo image


Page 422«..1020..421422423424..430440..»

Nanomedicine Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast to 2027 – Owned

August 16th, 2020 12:55 am

New Jersey, United States,- The most recent Nanomedicine Market Research study includes some significant activities of the current market size for the worldwide Nanomedicine market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Nanomedicine business status, presents volume and worth, key market, product type, consumers, regions, and key players.

The COVID-19 pandemic has disrupted lives and is challenging the business landscape globally. Pre and Post COVID-19 market outlook is covered in this report. This is the most recent report, covering the current economic situation after the COVID-19 outbreak.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Nanomedicine market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Nanomedicine Market, By Type

Nanomedicine Market, By Application

Other important inclusions in the Nanomedicine market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Surgical Robots Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Hypoallergenic Infant Formula (CMPA) Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Industrial Vision Systems Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Water Quality Monitoring Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Crystal Oscillators Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

See the rest here:
Nanomedicine Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies and Forecast to 2027 - Owned

Read More...

Whole-body welfare helps immunity: Ask the Doctors – GoErie.com

August 15th, 2020 9:52 am

You dont really want to "boost" your immune system.

Q: I always seem to get sick when I start a job. Makes sense new people, new germs. I started a job in February, then we all had to work from home. I worry that being isolated for weeks puts me back at square one. What can I ado to boost my immunity in preparation for going back to the office?

A: We're always happy to have this particular discussion, because the strategies and habits involved in addressing immune health also tend to lead to improved health overall. The immune system plays an important role in protecting us from all sorts of potential pathogens, and you're not alone in wondering how to give it an edge.

First, let's clarify the goal. We hear a lot about "boosting" the immune system, but that's actually misleading. You don't want an amped-up immune system. That would mean that it's hyper-alert and reacts and overreacts to every perceived threat. Rather, the goal is an immune system that's healthy and balanced and responds in proportion to the job at hand.

One of the most important steps you can take to keep your immune system happy and healthy involve lifestyle. That is, get an adequate amount of high-quality sleep, take part in daily exercise, don't smoke, limit alcohol use and eat a healthful diet. When you're chronically tired, depressed or anxious, overweight, eat poorly, smoke, drink too much and don't get enough exercise, you're creating internal stressors that can interfere with optimal immune system response.

Diet plays an important role in immune system health. Emerging research continues to link the health and diversity of the gut microbiome with the health and efficacy of the immune system. We urge our patients to get the necessary vitamins and minerals through food, which we believe the body utilizes more efficiently than supplements. Plenty of fresh vegetables, leafy greens and fruit are crucial to getting a range of vitamins and minerals and to keeping the billions of microorganisms that make up our gut microbiomes well-fed. So are nuts, seeds, beans and legumes. Cultured and fermented foods, such as pickles, sauerkraut, yogurt, kombucha, kefir and miso help with diversity.

We know it's a challenge, but steering clear of added sugar, sugary soft drinks and highly processed foods is also important to both gut and immune health. Recent studies have shown that regular exercise improves gut health. Sleep is also critical to health and well-being. We've had a lot of readers asking for help in this area, and we will revisit the topic in a column in the next few weeks.

We understand that, compared with the vitamins and supplements and products that promise instant immune system magic, this advice sounds pretty dull. But our bodies are intricate and interconnected mechanisms. Everything from circadian rhythms, which are affected by sleep, to the gut microbiome, which is affected by diet and exercise, to mood, which responds to all three, play a role in immune health. Focusing on a whole-body approach, with gradual but consistent changes, goes a long way toward building an immune system that's balanced and ready to work for you.

Send your questions to askthedoctors@mednet.ucla.edu, or write: Ask the Doctors, c/o UCLA Health Sciences Media Relations, 10880 Wilshire Blvd., Suite 1450, Los Angeles, CA, 90024.

See the original post:
Whole-body welfare helps immunity: Ask the Doctors - GoErie.com

Read More...

Can boosting the immune system treat COVID-19? – Futurity: Research News

August 15th, 2020 9:52 am

Share this Article

You are free to share this article under the Attribution 4.0 International license.

Boosting the immune system could offer a potential treatment strategy for COVID-19, according to a new study.

As the COVID-19 pandemic continues to claim lives around the world, much research has focused on the immune systems role in patients who become seriously ill.

A popular theory has it that the immune system gets so revved up fighting the virus that, after several days, it produces a so-called cytokine storm that results in potentially fatal organ damage, particularly to the lungs.

Some drugs tamp down the immune response, while others enhance it. Everybody seems to be throwing the kitchen sink at the illness.

But the new findings point to another theory and suggest that patients become ill because their immune systems cant do enough to protect them from the virus, landing them in intensive care units.

Researchers detailed the new strategy to boost the immune system in two papers, in JAMA Network Open and in the journal JCI Insight.

People around the world have been treating patients seriously ill with COVID-19 using drugs that do very different things, says senior investigator Richard S. Hotchkiss, professor of anesthesiology, of medicine, and of surgery at Washington University in St. Louis.

Some drugs tamp down the immune response, while others enhance it. Everybody seems to be throwing the kitchen sink at the illness. It may be true that some people die from a hyperinflammatory response, but it appears more likely to us that if you block the immune system too much, youre not going to be able to control the virus.

We think if we can make our immune systems stronger, well be better able to fight off this coronavirus

The researchers have been investigating a similar approach in treating sepsis, a potentially fatal condition that also involves patients who simultaneously seem to have overactive and weakened immune systems.

Hotchkiss points to autopsy studies performed by other groups showing large amounts of coronavirus present in the organs of people who died from COVID-19, suggesting that their immune systems were not working well enough to fight the virus.

His colleague, Kenneth E. Remy, first author of the JCI Insight paper, compares efforts to inhibit the immune system to fixing a flat tire by letting more air out.

But when we actually looked closely at these patients, we found that their tires, so to speak, were underinflated or immune-suppressed, says Remy, assistant professor of pediatrics, of medicine, and of anesthesiology.

To go and poke holes in them with anti-inflammatory drugs because you think they are hyperinflated or hyperinflamed will only make the suppression and the disease worse.

After gathering blood samples from 20 COVID-19 patients at Barnes-Jewish Hospital and Missouri Baptist Medical Center in St. Louis, the researchers employed a test to measure the activity of immune cells in the blood. They compared the blood of those patients to 26 hospitalized sepsis patients and 18 others who were very sick but had neither sepsis nor COVID-19.

They found that the COVID-19 patients often had far fewer circulating immune cells than is typical. Further, the present immune cells did not secrete normal levels of cytokinesthe molecules many have proposed as a cause of organ damage and death in COVID-19 patients.

Instead of trying to fight the infection by further interfering with the production of cytokines, they tried a strategy that has been successful in previous studies they have conducted in sepsis patients.

Hotchkiss and Remy collaborated with researchers in a small study conducted in seriously ill hospitalized COVID-19 patients in Belgium.

In that study, which the researchers reported on in the JAMA Network Open paper,researchers treated the COVID-19 patients with a substance called interleukin-7 (IL-7), a cytokine, required for the healthy development of immune cells.

In those patients, the researchers found that IL-7 helped restore balance to the immune system by increasing the number of immune cells and helping those cells make more cytokines to fight infection.

The research did not demonstrate, however, that treatment with IL-7 improved mortality in COVID-19 patients.

This was a compassionate trial and not a randomized, controlled trial of IL-7, Remy explains. We were attempting to learn whether we could get these immune cells working againand we couldas well as whether we could do it without causing harmful effects in these very sick patientsand there were none.

As this was an observational study involving a small number of patients who already were on ventilators, it wasnt really designed to evaluate IL-7s impact on mortality.

Studies focused on boosting immunity and improving outcomes among the sickest COVID-19 patients are just getting underway in Europe, and similar trials are starting in the US, including at Washington University.

Finding ways to boost the immune response should help not only in COVID-19 patients but when the next pandemic arises, Hotchkiss says.

We should have been geared up and more ready when this pathogen appeared, he says. But what Ken and I and our colleagues are working on now is finding ways to boost the immune system that may help people during future pandemics. We think if we can make our immune systems stronger, well be better able to fight off this coronavirus, as well as other viral and bacterial pathogens that may be unleashed in the future.

Source: Washington University in St. Louis

Follow this link:
Can boosting the immune system treat COVID-19? - Futurity: Research News

Read More...

COVID-19 and pregnancy: what we know about what happens to your immune system – The Conversation UK

August 15th, 2020 9:52 am

Any new infectious disease poses unique challenges to people who are pregnant during an outbreak. The effects of Sars, Zika and influenza in pregnancy highlight the potential immediate and longer term detrimental health outcomes a virus can have for both mother and baby. These risks include premature delivery of the baby with Sars, birth defects with Zika and greater risk of severe influenza.

Should we be as worried about pregnancy and COVID-19? There are a number of things we need to think about. These fall into two broad areas related to the effects on the foetus and the effects on the pregnant person themselves.

In both cases we need to think about the immediate effects during the pregnancy as well as the longer term health effects for both parent and child. The early evidence we have shows that changes to the immune system during pregnancy could be somewhat protective against the disease.

Early data from pregnant women with COVID-19 indicates that the disease is linked to premature birth and changes to the placenta that might reflect altered blood flow. This suggests that virus-associated disruptions do occur between parent and foetus.

However, these studies were of women with severe cases of the disease. We know very little about the effect of mild disease or asymptomatic infection in pregnancy. Understanding this is critical, as studies have highlighted that asymptomatic and mildly infected pregnant women far outnumber those requiring hospitalisation for COVID-19.

This indicates that pregnant people are not more susceptible to severe COVID-19, which was one of the greatest concerns at the beginning of the pandemic and led to them being categorised as vulnerable.

The apparent protective effect of pregnancy against severe disease might simply reflect the different immune responses to severe COVID-19 seen in men and women, and the fact that more men than women die from the disease in general. However, we do not see the same response in pregnancy with other viruses, such as influenza, suggesting something else is at play with SARS-CoV-2.

So far, it seems that the foetus is very well protected from the passage of SARS-CoV-2 from mother to child (known as vertical transmission) and such passage, while possible, seems to be uncommon. This might be down to the natural features of the placenta, which produces molecules that stop the virus binding to placental cells. It could also be that the placental membranes limit infection by the virus.

Of course, it is very difficult to study the placenta prior to birth. Alternative measures, such as analysing cellular debris released from the placenta (known as extracellular vesicles) which can be found in a sample of the mothers blood, are really needed to find out what features of the placenta might protect the foetus from infection and what effects the virus has on the placenta.

Any antibodies that a mother infected with SARS-CoV-2 makes will pass to the foetus across the placenta (known as passive immunity). This provides short-term protection from many infectious agents for the last months of pregnancy and for some months after the baby is born. These antibodies will also continue to be provided in breast milk if the baby is breast fed.

Early studies from China have shown that antibodies that protect against COVID-19 are present in newborns of women who had such antibodies. This confirms that passive immunity, where a baby essentially inherits antibodies from a parent, occurs with SARS-CoV-2. We now need some larger studies to investigate whether anti-SARS-CoV-2 antibodies are present in human milk to better understand the role of these antibodies in neutralising the virus and protecting the baby.

Molecules other than antibodies can also pass from parent to foetus. Pregnant women with severe COVID-19 have many of the hallmarks of an inflammatory response that we see in other people with similar symptoms. This includes elevated levels of molecules such as interleukin-6 (IL-6), which indicates that the immune response has been activated.

There are a number of studies showing that maternal immune activation can have detrimental effects on the developing foetus. Such activation is associated with increased risk of respiratory, cardiovascular, neurodevelopmental and other disorders in the offspring. Whether SARS-CoV-2 will have such long-term effects on the health of these children remains to be seen.

In a previous article, we discussed how the immune system changes during pregnancy, and it might be that unique features of this and other dynamic adaptations that occur with pregnancy provide protection from severe COVID-19.

Other examples of possible protective mechanisms include differences in the receptor molecules used by SARS-CoV-2 to invade human cells. Angiotensin-converting enzyme 2 (ACE2) is the best known of these viral entry receptors but CD147, CD26 and others also have this role.

All of these receptors undergo changes during pregnancy, which might contribute to resilience. These receptors also occur as soluble forms that can be measured in blood and breast milk and might act as decoy receptors, stopping the virus from binding to cells.

Elaborating on why both the pregnant person and their child seem to be relatively resilient to severe forms of COVID-19 might help us understand other disease processes and identify ways to combat the disease.

Work from the UK Obstetric Surveillance System has shown that, as with the wider population, Asian and Black pregnant women are more likely to be admitted to hospital with SARS-CoV-2 infection. Therefore, we really need to consider the effects of ethnicity and other risk factors in our studies of COVID-19 in pregnancy.

This is especially important as these studies will support efforts towards the use of any vaccine in pregnancy.

Read the original here:
COVID-19 and pregnancy: what we know about what happens to your immune system - The Conversation UK

Read More...

Explained: How the immune system goes awry in severe Covid-19 cases – The Indian Express

August 15th, 2020 9:52 am

By: Express News Service | New Delhi | Updated: August 14, 2020 9:11:20 amA doctor attends to a Covid-19 patient in Argentina. (AP Photo: Natacha Pisarenko)

Why are some Covid-19 cases more severe than others? A new study has uncovered deviations and lapses in the immune system that appear to spell the difference between severe and mild cases of Covid-19.

The difference, the study suggests, may stem from how our evolutionarily ancient innate immune system responds to SARS-CoV-2, the novel coronavirus that cases Covid-19. The innate immune system rapidly senses pathogens, and immediately launches a somewhat indiscriminate attack on them. It also mobilises precisely targeted, but slower sharp-shooter cells from the adaptive immune system (which is different from the innate immune system).

These findings reveal how the immune system goes awry during coronavirus infections, leading to severe disease, and point to potential therapeutic targets, senior author Bali Pulendran of Stanford Medicine said in a statement. The study is published in Science.

The researchers analysed the immune response in 76 people with Covid-19 and in 69 health people. They found enhanced levels of molecules that promote inflammation in the blood of severely ill patients. Three of these molecules are known to be associated with lung inflammation in other diseases, but had not been shown previously in Covid-19 infections.

Source: Stanford Medicine News Center

The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Explained News, download Indian Express App.

The Indian Express (P) Ltd

Original post:
Explained: How the immune system goes awry in severe Covid-19 cases - The Indian Express

Read More...

Alcohol addiction: could the brain’s immune system be the key to understanding and treating alcoholism? – The Conversation UK

August 15th, 2020 9:52 am

Alcohol abuse is a serious problem worldwide. In England alone, over 350,000 alcohol-related hospital admissions and over 5,000 alcohol-related deaths were reported in 2018. Long-term alcohol abuse can have many harmful effects on our body. But one of the organs most affected by alcohol is the brain. Even moderate consumption changes brain structure and leads to cognitive issues, such as declines in memory and problem-solving.

Alcohol use is habit forming and can eventually lead to alcoholism. And though there are many treatments available for alcoholism, research shows these interventions often fail with less than 20% of patients remaining alcohol free after intervention. Like every addiction, alcoholism is a disease and not a choice, so finding the root cause of it will make treatment easier.

Although genetics and the environment you live in are known to play a role in developing alcoholism, these factors dont tell us how dependence occurs.

However, past research has found hints that the brains immune system cells (known as microglia) may be involved in addiction, including to cocaine and tobacco). One study even found that alcohol exposure and withdrawal in rats increased microglia numbers in the brain, before any other signs of alcohol-induced decline.

Another two recent studies have investigated brain changes seen in people and animals with alcohol dependence. Each of these studies found a common culprit: inflamed microglia.

Microglia are the brains resident immune system cells. Their main role is to guard and maintain balance in the brain. When microglia detect a threat, they respond by becoming inflamed and attacking. Normally, they return to normal after the threat is gone, but sometimes when inflammation becomes uncontrollable such as with Alzeimers disease it can lead to brain degeneration.

One recent study used mice to study the effect of alcohol dependence on the brain.

In the brains of male mice that had alcohol dependency, research found there were more microglia cells in the medial prefrontal cortex, a region associated with pain, decision making, and memory processes. Similar results have also previously been found in humans.

They then examined what effects microglia depletion had on alcohol dependent mice by looking at their alcohol seeking behaviour, and anxious behaviour during alcohol withdrawal. The researchers found both factors were lowered when the microglia cells were reduced in the brain.

They also saw gene changes with microglia depletion. Genes involved in inflammation and immune responses were expressed less after depletion. The expression of genes involved in alcohol consumption, and alcohol dependence also changed when microglia had decreased. They also found that microglia depletion weakens brain circuits involved in the development of dependence and relapse behaviour in rodents.

A second study looking at both rodent and human brains also showed microglia is involved in alcohol dependence.

The researchers of this study used brain imaging, microglia depletion, and studies of post mortem brains, to examine changes that occur in alcohol dependence. For the brain imaging part, they used a variation of MRI scans, called DTI-MRI in humans and rats, focusing on a measure called mean diffusivity.

As DTI-MRI is based on the diffusion of water in tissues, mean diffusivity essentially shows the amount of diffusion of water molecules in tissues, with more dense and structurally-intact tissues having lower mean diffusivity. Mean diffusivity has previously been shown to change in the brain in inflammatory and degenerative conditions (including Alzheimers Disease and even psychosis). The researchers therefore chose to look at mean diffusivity as neuroinflammation is also involved in alcoholism. The researchers wanted to examine whether changes in mean diffusivity would be found between alcoholics and non-alcoholics, which hasnt been done before.

Indeed their findings showed that mean diffusivity is overall higher in the brain of alcohol dependent rats and humans. They also found additional changes in how certain neurotransmitters including dopamine, which is involved in alcohol dependence move and are distributed in the brain.

The researchers went on to examine the microglia in the brains of rats with alcohol dependence, and rats with previous dependence who had abstained from alcohol for a week. They found a decreased amount of microglia in specific brain regions of dependent rats (including the hippocampus, which is involved in memory, and the nucleus accumbens, which is involved in the reward system). The microglia in the brains of alcohol dependent rats were also in their inflamed form.

Although this study showed a decrease in microglia numbers whereas the previous study saw an increase this might be because the researchers looked at different brain regions and used different research methods and animal models. However, both studies give hints towards how microglia functions during alcohol consumption and dependence, may differ in different brain regions.

The researchers also found that depleting microglia from the brain, or inducing microglias inflammatory response, led to similar results to each other, as both increased the mean diffusivity. Changes in microglias form when inflamed were also similar to the ones they observed in dependent rats. They concluded that the changes in the brain areas they studied could be explained by an inflammatory reaction of microglia caused by alcohol.

One limitation of both studies findings is that they used both only male rodents and male humans. However, both studies exhibit how alcoholism is a complex disease that produces clear changes in the brain.

Examining how exactly microglia is involved, and being able to interfere with their responses, could lead to better understanding and detection of addiction to alcohol, and give a good stepping stone for future targeted interventions.

Visit link:
Alcohol addiction: could the brain's immune system be the key to understanding and treating alcoholism? - The Conversation UK

Read More...

Are you immune to COVID-19 for three months after recovering? Its not clear – WTOP

August 15th, 2020 9:52 am

It's the question everyone wants answered: How long are we protected from catching COVID-19 after we've recovered from the novel coronavirus?

Its the question everyone wants answered: How long are we protected from catching Covid-19 after weve recovered from the novel coronavirus and what does that really mean?

Last week, the US Centers for Disease Control and Prevention updated its quarantine guidelines online to say that people who have recovered from Covid-19 do not need to quarantine or get tested again for up to three months but the agency clarified in a statement to CNN on Friday that does not mean that people are immune to reinfection.

People who have tested positive for COVID-19 do not need to quarantine or get tested again for up to 3 months as long as they do not develop symptoms again, the CDC guidance stated.

A CDC spokesperson said the guidance is based on the latest science about COVID-19 showing that people can continue to test positive for up to 3 months after diagnosis and not be infectious to others.

Yet this science does not imply a person is immune to reinfection with SARS-CoV-2, the virus that causes COVID-19, in the 3 months following infection. The latest data simply suggests that retesting someone in the 3 months following initial infection is not necessary unless that person is exhibiting the symptoms of COVID-19 and the symptoms cannot be associated with another illness, the CDC statement said.

I think this is an incredibly sticky wicket, as the British would say, said Dr. William Schaffner, a professor of preventive medicine and infectious diseases at Vanderbilt University School of Medicine in Nashville, who was not involved in the CDC guidance.

We think antibodies correlate with protection, but we dont really know that yet, Schaffner said.

Practical applications, Schaffner added, are still a long way off. Can a person who has antibodies begin to date or stop wearing a mask, for example? Absolutely not, he said emphatically.

Our adaptive immune system, designed to target a specific and previously recognized invader, contains two main cellular components B cells and T cells. Studies on immunity so far have focused mainly on B cells, a type of white blood cell programmed to find and bind to foreign invaders.

Once it has attached itself to a virus such as the novel coronavirus that causes Covid-19, a B cell copies itself and churns out antibodies, eventually creating a mega-army of neutralizers for that particular invader, said CNN Chief Medical Correspondent Dr. Sanjay Gupta in an explainer on virus immunity.

Unfortunately, a few recent studies have found that antibodies to this particular coronavirus can fade away pretty quickly especially in people who have had mild cases of Covid-19, Gupta said.

A pre-print paper (meaning it has not been published in a peer-reviewed journal) released in July found antibody responses appear to decline 20 to 30 days after Covid-19 symptoms first appear.

This study has important implications when considering protection against re-infection with SARS-CoV-2 and the durability of vaccine protection, the researchers wrote in the paper.

In June, a small study found that people who have coronavirus infections but never develop symptoms could have weaker immune responses to the virus.

That study found that a group of about three dozen Covid-19 patients who were asymptomatic had levels of antibodies that were significantly lower than what was found among patients who had mild symptoms a finding that suggests the asymptomatic patients had weaker immune responses.

In early July, a Spanish government study found that just 5% of people in Spain have coronavirus antibodies and in a potentially worrying development, the study also indicated that peoples immunity to coronavirus wanes after just a few weeks. The findings show that 95% of Spains population remains susceptible to the virus.

This means that any perceived immunity can be incomplete, transitory and then disappear, said Dr. Raquel Yotti, head of the Carlos III Health Institute, in a news conference at the time. The institute is a key government agency leading the study.

Science is hoping that Covid-19 will also trigger an immune response from another arm of the adaptive immune system T cells. One type, called a memory T cell, helps the body remember a specific invader in case it comes back.

A recent study found such memory T cells in people infected with SARS-CoV-2, the novel coronavirus that creates the disease called Covid-19. That finding leads to speculation that some people might get milder cases of Covid-19 because their T-cells are reacting to exposure to similar coronaviruses encountered in the past.

The virus SARS-CoV-2 belongs to a large family of coronaviruses, six of which were previously known to infect humans. Two are deadly: SARS-CoV-1, the virus responsible for the outbreak of Severe Acute Respiratory Syndrome (SARS), which ended in 2004; and MERS-CoV, the virus that causes Middle East Respiratory Syndrome (MERS).

The other four cause the common cold, and because they circulate widely each year, its possible many people may have already been exposed to one of these so-called cousins of the novel coronavirus.

Theyve been studied and we know that after you had a cold, you develop antibodies to that particular human strain of coronavirus and you will be protected, but it turns out the protection begins to wane after about a year, Schaffner said.

Now when Covid-19 came along, we wondered how much protection are you going to get from this virus? And if you get protection, how long does it last? he added. We dont know that behavior yet.

Another page on the CDC site, updated in June, refers to the uncertainty that exists surrounding the role of antibodies in future infections.

Having antibodies to the virus that causes COVID-19 might provide protection from getting infected with the virus again. If it does, we do not know how much protection the antibodies might provide or how long this protection might last, the CDC says in regard to testing.

Until science knows more about how long immunity lasts, Schaffner advised staying the course of what is known to work: hand-washing, social distancing, avoiding crowds and wearing masks.

Dont go around looking for reasons not to wear the mask, just wear it. Get used to it, Schaffner said. We want to all be in this together to affirm our solidarity.

Editors note: This article has been updated to include comment from CDC clarifying its quarantine guidance.

See the original post here:
Are you immune to COVID-19 for three months after recovering? Its not clear - WTOP

Read More...

Cleveland Clinic: Four ways to boost your immune health – WKYC.com

August 15th, 2020 9:52 am

Amid the pandemic, staying healthy is a top priority for most.

CLEVELAND As the state of Ohio continues it's fight against thecoronavirus pandemic, staying healthy seems to be a top priority for everyone.

But outside of washing your hands, not touching your face and proper social distancing, how can you increase your health and overall wellness? The Cleveland Clinic recommends boosting your immune system.

You diet can have a huge impact on your immune Health.

I believe in the power of immune-boosting foods, says Dr. Darling. Choosing whole, unprocessed foods does wonders for overall health, says Preventive medicine physician and wellness expert Sandra Darling.

She suggests adding foods like garlic, prebiotics, vitamin C-rich foods, and antioxidants to your diet to give your system a boost.

Listen, we know it's hard, but living under constant stress is detrimental to the body. Too much stress "cause causes the body to produce too much cortisol, the stress hormone. Over time, elevated cortisol lowers your resistance to fighting off infection and contributes to poor sleep and higher blood pressure," according to the clinic. Dr. Darling suggests making sure you get enough sleep, exercise and try meditation.

A little bit of positivity goes a long way. "Research shows that positive thoughts reduce stress and inflammation and increase resilience to infection while negative emotions can make you more susceptible to the common cold and flu," according to the Clinic.

If you've done all that you can when it comes to taking care of your immune system health, the Clinic recommends trying supplements and or essential oils.

The Clinic also recommends making sure you're taking time for yourself to rest in recharge. There's a lot going on in the world, you can't pour from an empty cup--so fill yours up!

For more information on the Clinic tips and resources, click here.

Continued here:
Cleveland Clinic: Four ways to boost your immune health - WKYC.com

Read More...

The Right Wing Has A New Theory For Why The Pandemic Will End Soon: T Cells – BuzzFeed News

August 15th, 2020 9:52 am

How the immune system responds to the coronavirus is a mystery that scientists are working furiously to unravel but their findings are being weaponized to make unfounded claims that the pandemic isnt a big threat.

That became clear this week, when President Donald Trump unveiled his newest science adviser on the coronavirus task force, neuroradiologist Scott Atlas. A senior fellow at Stanford Universitys Hoover Institution, he has steadily promoted unscientific views about the virus on Fox News and elsewhere, and has said there is zero excuse to not have the schools open in person. On Monday, Rush Limbaugh said Atlas was countering Fauci and cited the new advisers baseless theory that we could well be burned out of COVID by October. The reason: prior immunities.

Also on Monday, an unlicensed ophthalmologist and cryptocurrency investor, James Todaro, went viral on Twitter with a similarly misleading screed. Todaro, who was in the viral Americas Frontline Doctors video shared by Trump and removed from social media platforms for spreading misinformation about hydroxychloroquine, falsely claimed that T cell immunity meant many regions were already safe from infection and that lockdowns and mask-wearing were likely useless.

But infectious disease experts say these claims grossly distort the underlying science and what it means for public health guidelines which, right now, is nothing.

The apparent basis for these statements: a slew of recent studies finding that, in some places, 20% to 50% of people have immune cells that unexpectedly recognize the coronavirus. The newest of these studies suggests that these cells exist because they have responded in the past to similar viruses that can cause colds.

But the significance of this finding remains an open question, as its unclear what role, if any, these cells play in the bodys overall response to the coronavirus. And there is still no evidence that having these cells from a past cold will save you from getting COVID-19.

As T cells become yet another politicized flashpoint, scientists say the bottom line is that none of these findings make COVID-19 any less of a threat. The research should not be used, they warn, to argue against shutdowns and masks or for reopening workplaces and schools in a developed nation that has uniquely failed to control the virus. Most of all, they reject the leap of logic that the research means society is close to herd immunity the point at which enough people are immune to a virus that it stops circulating.

Weve got 1,000 people dying a day in the country, Shane Crotty, an immunologist at the La Jolla Institute for Immunology who has worked on several of the recent T cell studies, told BuzzFeed News. Theres no change in what the virus is doing based on what I find out or anybody else finds out. The virus is doing its thing and were doing our best to understand it.

The claim that T cells could mean the pandemic will end in two months, he said, is a total misunderstanding and wishful thinking.

Since the outset of the pandemic, Crotty and scientists around the world have been racing to untangle how the virus wreaks havoc on the body and how the body fights back.

The immune system employs different mechanisms to recognize and attack intruders. Perhaps the best-known of the bunch are antibodies, the proteins that latch onto and neutralize viruses and other invading substances. But in people who recover from the coronavirus, antibodies may only protect against reinfection for three months, recent research suggests.

Another weapon in the immune systems armory is T cells, which come in an assortment of types and functions and are increasingly garnering scientific attention. In the Netherlands, Germany, Singapore, the United Kingdom, and the US, researchers have discovered that in some people, a specific subset of T cells recognized the new coronavirus, SARS-CoV-2, when exposed to it. This was surprising, because these kinds of T cells, by definition, were not expected to recognize a virus they had never encountered before.

In their paper published last week in Science, Crotty and his team reported an explanation for why these cells reacted. Using human blood samples collected prior to the pandemic, they found cells that reacted to both SARS-CoV-2 and to four other coronaviruses that cause common colds. These coronaviruses, the researchers said, were apparently similar enough to the new one to make the T cells cross-reactive. (Crotty likened SARS-CoV-2 to a pretty distantly related evil cousin.)

The finding has led scientists to speculate that these cross-reactive T cells could be behind one of the pandemics biggest mysteries: why the virus causes severe illness in some people but mild or no symptoms in others. The latter patients might be better equipped to handle an infection, having fought off related viruses before. Childrens immune systems have to fight off a lot of colds, so maybe this is why they seem to be relatively spared by the new virus.

For now, however, this theory is just that: a theory.

It could explain everything and it could explain nothing, Crotty said. Very truly, these cells may have no impact on the disease at all. And even if this theory were borne out, it would have significant limits: As he noted, colds are caused by hundreds of viruses, not just the four identified in the study.

Either way, these cells are still just one piece of the immune system, a highly intricate machine with all kinds of T cells and antibodies working independently and together to stamp out pathogens. The big, yet-to-be answered questions are which of these elements actually protect people from getting sick and for how long.

While T cells may offer some protection and thats not really known T cells would probably not just prevent a person from being infected altogether, said Angie Rasmussen, a virologist at Columbia University who is not involved with this research.

But uncertainty hasnt stopped pundits from twisting the research to make a point.

On July 23, before he was appointed to the White Houses coronavirus task force, Scott Atlas declared on Laura Ingrahams show that lockdowns would not eradicate the virus, that the US outbreak was not out of control, and that there is absolutely no reason to panic, arguments hed been making since the spring. That day, the nations case count passed 4 million.

Theres a lot of great data coming out about immunity, Atlas went on to say. Its probably not known to the public, but there is a lot of data that shows that people have immunity even people that didnt get the infection. He added, Thats probably due to this T cell immunity, and concluded, So I think people should be much more optimistic here. The Fox News host responded enthusiastically, saying shed been discussing T cells and what they could mean for herd immunity on the show for well over six weeks.

This week, Limbaugh cited Atlass theory to tell listeners that the pandemic was almost over. We could see by early October COVID-19 turn inert or dormant largely due to some underappreciated T cell, prior immunities from exposure to coronavirus, meaning colds and so forth, the conservative radio host explained. Some people who have come down with a cold over the course of the summer miraculously end up less likely to get COVID-19, according to Scott Atlas. And people that get colds, thats a large portion of the population.

Atlas directed a request for comment to White House spokesperson Judd Deere, who said in a statement that Atlas is a world renowned physician and scholar of advanced medical care and health care policy who, like all of the medical experts in the Administration, is working to carry out the Presidents number one priority: protecting the health and safety of the American people.

Deere added, We are all in this fight together, and only the media would distort and diminish Dr. Atlas highly acclaimed career simply because he has come to serve the President.

Around the same time Limbaugh was praising Atlass theory, a similar claim was gaining traction on James Todaros Twitter account. Todaro, an early and avid proponent of hydroxychloroquine, is an ophthalmologist who earned his medical degree at Columbia University. He has not practiced since 2018, according to his LinkedIn profile, and his Michigan medical license expired last year. He did not respond to a request for comment.

In his thread, Todaro claimed that Crottys studies and others were growing evidence of T-cell immunity. All those runny noses from the common cold prepared our T cells to fight COVID-19, he proclaimed. He calculated that if about 50% of people had T cell immunity prior to SARS-CoV-2, and an additional 10% to 20% of people were newly infected, then 60% to 70% of the population would be immune a threshold that he said reached herd immunity.

It is likely that many of the hardest hit regions of the world (e.g. Lombardy, NYC, Madrid, London, Stockholm) are now at herd immunity, he wrote. Lockdowns & mask ordinances (mostly coming after the peak) likely had little effect, with the exception of perhaps prolonging the spread.

Thats not at all what the T cell research suggests, however. Having these cells still means you can get infected, only maybe maybe not as badly as if you didnt have them.

Herd immunity implies immunity, not just fewer people getting severe disease, said Gideon Meyerowitz-Katz, an epidemiologist at the University of Wollongong in Australia. That means they do not catch it, do not spread it, they have this immunity that stops them from getting it in the first place.

Even if 50% of the population really were somehow immune to the virus, that wouldnt change the number of people who have been hospitalized and killed by the pandemic. As of Friday, the death toll in the US had exceeded 167,000. It doesnt change anything from the public health side of things, Meyerowitz-Katz said.

Nevertheless, Todaros 19-part thread has been retweeted more than 48,000 times. It has circulated among figures on the right, from a Minnesota state senator to an editor at the Conservative Review to an ex-lawyer who has been retweeted by Trump. Other retweeters included the World Health Organizations director of epidemic and pandemic diseases, and a Scottish historian who shared it with his more than 1 million followers: Interesting thread. And hopeful if true.

Crotty is not a heavy Twitter user he checks it about once a week but he felt compelled to respond once he saw how far the misinformation was spreading. It was just not understanding the science, he said.

He banged out a series of counterpoints, explaining why Todaros claims were dangerous and unfounded. Nothing about his findings, he stressed, should change what the public should already be doing to stem transmission. Wearing a mask is much more effective than hoping you and the people around you have pre-existing T cell memory. Wearing a mask stops infections.

His debunk was retweeted more than 3,700 times, a mere fraction of Todaros reach.

Rasmussen, the Columbia virologist, worried that most people watching Fox News or coming across Todaros tweets would never see Crottys attempt to correct the record. As she put it: Theyre just going to look at, Oh, heres this big thread on T cell immunity. This sounds great. We dont even need to worry about waiting for a vaccine.

And she pointed out that this isnt the first time during the pandemic that seemingly credible sources have injected misinformation into the mainstream.

Weve seen this a few times: People essentially using the clout of their credentials or their affiliations with a prestigious university to get them onto TV basically and amplify these messages, Rasmussen said. The overarching message, as she saw it, is the standard Trump administration downplaying of the severity of the pandemic, saying that this is not as a big of a deal as everybody makes it out to be. Which, of course, the epidemiological evidence of over 160,000 deaths suggests otherwise.

During an interview on Wednesday, it was still dawning on Crotty that his research had suddenly, unwittingly, become another political flashpoint.

2020, the immunologist said. The year when all kinds of unexpected things happen.

More here:
The Right Wing Has A New Theory For Why The Pandemic Will End Soon: T Cells - BuzzFeed News

Read More...

These groundbreaking drugs will give us coronavirus immunity until vaccines are ready – BGR

August 15th, 2020 9:52 am

Theres no guarantee theyll work, but health experts are hopeful that the first vaccine candidates to have reached the final stage of testing might be available as soon as this fall or winter. They still have to convince regulators that theyre safe and effective against the novel coronavirus, and thats the purpose of the large scale Phase 3 studies that are currently underway in the US and around the world. But even if some of these experimental drugs are ready for emergency use by late 2020, the general public wont have access to them until several months later, well into 2021. Logistics and manufacturing issues need to be ironed out before officials can start immunization campaigns, and healthcare professionals will rightfully have access to vaccines before the general public. Even then, only specific high-risk categories of people might qualify for the first round of vaccinations.

Thankfully, the world isnt putting all its eggs in the vaccine basket when it comes to crafting COVID-19 therapies. Several teams of scientists are testing drugs that might cure COVID-19, including a type of medicine that can also provide temporary immunity to healthy people. And the good news is that these new medications that can provide a limited immunity might be ready even before vaccines roll out.

Anyone following pandemic news closely is probably aware that several companies are studying drugs made of artificial antibodies. The so-called monoclonal antibodies aim to block the coronavirus from infecting cells. Theyre crafted using various technologies, but the purpose is the same. The antibodies can bind to the spike proteins found on the exterior of the virus and prevent them from linking up with cells. This is how the immune system works against any pathogen it creates neutralizing antibodies that can annihilate it.

Vaccines will teach the human body to prepare for COVID-19 by mimicking the virus and inducing neutralizing antibodies. Thats how long-term immunity can be obtained. Its unclear how long the protection will last, but vaccine immunity should significantly outlast monoclonal antibody immunity. Thats because the artificial antibodies provide immunity themselves and the protection is only good as long theres a circulating supply in the bloodstream. Once they vanish, the body wont know how to make more antibodies when needed, which is what would happen after vaccination or after surviving the illness.

Monoclonal antibodies do have one significant advantage over vaccines. They can help COVID-19 patients recover, while vaccines can only prevent an infection. Plasma experiments have shown that antibodies from COVID-19 survivors can significantly improve the condition of COVID-19 patients. Monoclonal antibodies would work the same way. Theyll hopefully prevent complications and deaths, and they should also speed up recovery times.

These drugs could become a crucial tool in the coming months and could deliver results long before vaccines are widely available.

A vaccine takes time to work, to force the development of antibodies. But when you give an antibody, you get immediate protection, University of North Carolina virologist Dr. Myron Cohen told The Associated Press. If we can generate them in large concentrations, in big vats in an antibody factory we can kind of bypass the immune system.

These drugs would be a really momentous thing in our fight against COVID, the doctor said.

The AP story runs through the various monoclonal antibody drugs that are currently in testing, some of which weve covered before. Eli Lilly has already started manufacturing its drug in the hopes that current studies will prove its effectiveness. Regeneron Pharmaceuticals already inked a $450 million deal with the US governmentand its making a dual antibody compound that should work even if the virus mutates.

Amgen, Adaptive Biotechnologies, Tychan, and Vir Biotechnology have also crafted various monoclonal antibodies that might work against COVID-19. Another team of scientists created antibody-like nanobodies and turned them into an aerosol that could be used with a nebulizer or inhaler.

Some of the drugs would be administered intravenously, and the antibody supply could last as long as a month for some candidates, but the protection could be extended to two months by increasing the dose. Subsequent shots would be needed to prolong the protection. Its unclear how much these drugs will cost or how soon theyll be available, but all sorts of clinical trials are already underway. Some are looking at monoclonal antibody drugs as treatment for COVID-19, while others are studying their capability to provide limited immunity to at-risk patients.

Dr. Anthony Fauci is cautiously optimistic about these drugs, just like with vaccines. Im heartened by the experience that we had with Ebola, he said. Its the success with our Ebola program that gives Regeneron hope that we can potentially do this again.

Chris Smith started writing about gadgets as a hobby, and before he knew it he was sharing his views on tech stuff with readers around the world. Whenever he's not writing about gadgets he miserably fails to stay away from them, although he desperately tries. But that's not necessarily a bad thing.

View original post here:
These groundbreaking drugs will give us coronavirus immunity until vaccines are ready - BGR

Read More...

Study: existing tuberculosis vaccine is safe, stimulates the immune system, and may also be effective against COVID-19 – Innovation Origins

August 15th, 2020 9:52 am

It is the dream of both doctors and politicians: an existing vaccine, the safety of which has already been established and which can induce immunity to COVID-19. Part of the dream is already coming true, according to research by Radboudumc in Nijmegen. A vaccine against tuberculosis that has been used for years appears to have a general stimulating effect on the immune system. It, therefore, works effectively against several diseases. It remains to be seen whether COVID-19 is one of those.

The study compared groups of volunteers who may or may not have received a BCG vaccine in the last five years (before the corona pandemic) and showed that the vaccine is at least safe and does not pose any additional risk of COVID-19 complaints. The results of this study have now been published in Cell Reports Medicine.

The Bacille Calmette-Gurin or BCG vaccine is the most widely received vaccine in the world. Originally intended as a treatment for tuberculosis, it later became clear that it gives a long-term, general boost to the innate immune system. As a result, the vaccine also proved effective against other conditions. At the Radboudumc, Professor of Experimental Internal Medicine Mihai Netea does a lot of research into this effect, which is called trained immunity.

Most volunteers received the vaccine between April 2017 and June 2018. Doctor PhD student and first author of the article Simone Moorlag explains that the purpose of that study was to determine the difference in immune response between individuals. Weve now asked the same volunteers about disease and COVID-19 complaints during the coronary pandemic. We then compared these data with those of a group of healthy volunteers who did not receive a BCG vaccine.

What the comparison between the groups shows is that at least those who have received the vaccine have not become ill more often or have become more seriously ill. Therefore, the researchers conclude, it cant do any harm to vaccinate people with BCG. The data show a cautiously positive picture, with a lower number of sick people in the period March-May 2020 among the vaccinated group, and also fewer fatigue complaints.

For bigger conclusions, it is still too early. The researchers underline that the positive result was to be expected in view of the generally known effects of the BCG vaccine on healthy volunteers. Moreover, the study also has limitations that prevent conclusions from being drawn about the usefulness of the BCG vaccine for the coronavirus. Mihai Netea: It is very important to be able to confirm that someone who has been vaccinated with BCG does not experience any adverse effects during the COVID-19 pandemic. But he also stresses that more study is needed to determine if this vaccination against COVID-19 can really help.

In order to be able to determine this, various studies are already underway, including a number of major studies in the Netherlands.

Read more:
Study: existing tuberculosis vaccine is safe, stimulates the immune system, and may also be effective against COVID-19 - Innovation Origins

Read More...

These are the foods that strengthen your immune system.Dont stop consuming them! – Explica

August 15th, 2020 9:52 am

He immune system it is responsible for attacking and destroying bacteria, viruses and all infectious organisms that try to penetrate the body. But like any defense mechanism it requires good maintenance to strengthen it.

Spinach, lettuce, carrot, pumpkin, tomato, beet, strawberries and cherries. Source of Vitamin A, responsible for the production of cells immune known as T lymphocytes.

Foods rich in vitamin B12 Vegetables source of vitamin C

Fish, poultry, eggs, milk, derivatives of dairy products and legumes. Rich in b12 vitamin, key in the maintenance of the central nervous system and in the proper functioning of the body.

Vegetables source of vitamin C

Green leafy vegetables like broccoli, cauliflower and bell peppers, citrus fruits like orange, lemon, tangerine, kiwi and apple. Source of vitamin C, responsible for preventing the entry of infections through the respiratory tract.

Nuts (peanuts, almonds, hazelnuts and pine nuts), asparagus, fish and olive, sunflower, rapeseed, wheat germ and hazelnut oils. Rich in Vitamin E, has antioxidant properties and its function is to strengthen the immune system.

Go here to read the rest:
These are the foods that strengthen your immune system.Dont stop consuming them! - Explica

Read More...

Immune receptor thought to be linked to hearing loss in child cancer survivors confirmed in new study – Folio – University of Alberta

August 15th, 2020 9:52 am

ByYOLANDA POFFENROTH and MICHAEL BROWN

Permanent hearing loss triggered by a common chemotherapy drug in half of children being treated for cancer may occur through a well-studied immune receptor, according to University of Alberta research.

The study confirms a long-held belief and sets the stage for the development of safe doses tailored to each childs genetic makeup.

For the study, recently posted in bioRxiv, Ghazal Babolmorad, a PhD student in the Faculty of Medicine & Dentistry, focused her research on the immune response children with cancer have to cisplatin, a platinum-based chemotherapy drug that is highly effective in fighting the disease, but leads to serious side effects in 90 per cent of patients. These side effects include kidney and heart damage as well as permanent hearing loss in upwards of 60 per cent of children.

If were able make cisplatin, an otherwise invaluable chemotherapeutic tool, safe for everyonenot just low-risk patientsit could be a game-changer for the quality of life of the children using cisplatin as their cancer therapy, said Babolmorad.

The platinum atom at the centre of cisplatin is responsible for killing cancer cells, but can also activate an immune receptor in the cell membrane, known as TLR4, that experts have long thought plays a role in inflammation. Immune receptors are proteins that detect the presence of a pathogenor something wrong, like a cancer celland generate a signal to combat the pathogen.

The inflammation caused by the immune receptor that Babolmorad and her supervisor Amit Bhavsar were interested in occurs in the cochlea and results in damage to the auditory cells and, ultimately, hearing loss.

To better understand the mechanism behind this inflammation, th team treated two groups of auditory hair cell linessimilar to the ones found in human ears responsible for perceiving soundthat were essentially identical, except one of them lacked the TLR4 immune receptor, with platinum.

As expected, we only saw signals arise in the cells with TLR4, said Babolmorad. Basically, platinum, and cisplatin by extension, can activate the TLR4 immune receptor, which causes a response in the immune systemlike inflammation in the cochlea.

However, thanks to genetic variation, there are people who express a low level of this immune receptor, which means their immune system isnt activated and they have a low risk of developing hearing loss, said Babolmorad.

Babolmorad is now working with other U of A researchers, including groups led by chemistry professor Fred West and biology professor Ted Allison, to examine potential synthetic inhibitors that can block the TLR4 receptors.

Ghazal Babolmorads Graduate Studentship project is funded by the Stollery Childrens Hospital Foundation through the Women and Childrens Health Research Institute.

Read the rest here:
Immune receptor thought to be linked to hearing loss in child cancer survivors confirmed in new study - Folio - University of Alberta

Read More...

AVMA, affinity organizations working to advance diversity, equity, inclusion – American Veterinary Medical Association

August 15th, 2020 9:51 am

Representatives of 10 affinity organizations with a focus on diversity, equity, and inclusionled by the Multicultural VMAmet virtually with members of the AVMA Board of Directors and senior AVMA leadership on July 25. The meeting provided a forum for everyone to get to know each other and discuss a letter(PDF) that the organizations sent to AVMA leadership on July 19 outlining actions they would like to see.

The organizations are the Association of Asian Veterinary Medical Professionals, BlackDVM Network, Latinx VMA, Multicultural VMA, National Association for Black Veterinarians, Native American Veterinary Association, Pride Veterinary Medical Community, Pride Student VMC, Veterinarians as One for an Inclusive Community for Empowerment, and Womens Veterinary Leadership Development Initiative. The meeting also provided an opportunity for the AVMA to talk about its diversity, equity, and inclusion initiatives.

Everyone agreed that this is the time for action, according to a July 31 joint report on the meeting. The tragic deaths of George Floyd and Breonna Taylor, among others, have changed our world, and have created an increased sense of urgency.

Affinity group members gave an overview of recommended action items and identified the following priorities:

During the meeting, the affinity groups noted they had created a video that featured some of the nearly 400 stories they had collected of veterinary professionals sacrifices and struggles with regard to diversity, equity, and inclusion. Later, Dr. Douglas Kratt, now AVMA president, introduced the video when it was presentedat the AVMA House of Delegates regular annual session, held virtually July 30-31. Dr. Kratt emphasized that the AVMA is eager to listen, learn, and engage further with DEI organizations.

Discussion at the meeting between the AVMA and DEI organizations then moved to how many of the action items listed by the organizations align with the AVMAs DEI initiative currently in progress, according to the meeting report. AVMA representatives outlined the AVMAs work to date and described the following three main DEI strategies:

Several AVMA projects are underway that fit under these strategies, such as the Associations plan to retain outside DEI expertise to help identify areas of greatest need, set priorities, and use resources most effectively in this area.

In addition, the AVMA has ongoing mandatory DEI training for AVMA employees. The Association will consider expanding its training requirements to volunteers, although with a slightly different focus, the meeting report stated.

Another project is the Brave Space Certificate program, set to launch in the fourth quarter of 2020 on AVMA Axon, the AVMAs digital education platform. Pride VMC is the founding education partner for the certificate program. The program promotes work environments in which all individuals are treated fairly and respectfully, have equal access to opportunities and resources, and can contribute fully to the organizations success. The AVMA has dedicated considerable resources to this program, which was initiated in 2019 and will launch in Q4 2020, according to the meeting report.

Finally, the AVMA has been in initial talks with the Association of American Veterinary Medical Colleges and Veterinary Medical Association Executives, among others, to explore the establishment of a professionwide commission to examine DEI issues affecting the profession. A consensus on the entitys concept is expected by Oct. 1. The AVMA and DEI-focused organizations planned to meet again virtually in August.

We recognize that AVMA cannot do this job alone, the July 31 meeting report stated. These issues have a long and complex history, extend beyond the AVMA, and of course affect the entire profession and all of organized veterinary medicine. Thats why it is so critical to work together.

Read more:
AVMA, affinity organizations working to advance diversity, equity, inclusion - American Veterinary Medical Association

Read More...

A Rare Economic Bright Spot in the U.S. Health System: The Vets Office – The New York Times

August 15th, 2020 9:51 am

The human health care system has struggled financially through the coronavirus pandemic, losing billions from the cancellations of lucrative elective operations as patients were first told to stay away from hospitals and then were leery of setting foot in one.

The canine and feline health system, though, is booming.

Its crazy, in a good way, said Dr. Margot Vahrenwald, a veterinarian who co-owns Park Hill Veterinary Medical Center in Denver. Were probably seeing 25 percent more new pets than what we would normally. It feels busier, and were seeing increased revenue.

While hospitals were furloughing workers, Dr. Vahrenwald added five employees, and still has job listings for more. Her clinic has had to buy two phone lines to handle a deluge of calls from pet owners.

The phone lines were so busy that, if we were occupying them making calls out to clients, we would end up with 60 voice mail messages in a half-hour, she said.

Animal hospitals appear to have pulled off something human hospitals have struggled to do: make patients feel comfortable seeking routine care.

Most veterinarians are now requiring curbside service owners drop their pet at the door, and wait outside during the appointment lessening the risk of catching coronavirus.

Their animal patients tend to be less susceptible to coronavirus, although not completely immune. Some pets have become infected, and last month the first dog in the United States to test positive for the virus died.

Pet owners have, collectively, decided there is enough value in maintaining the health of their cats and dogs to brave the outside world at least a little more. Much of the increase in veterinary care seems to be for wellness visits and vaccinations. By contrast, primary care spending for humans is estimated to have dropped by $15 billion over the course of the pandemic.

The veterinary industry provides something else important that the human health system doesnt: transparent prices. Veterinarians can typically provide reliable price estimates, in part because they have standard charges that dont vary by type of insurance.

Patients may be reluctant to return to the human health system in part because theyve lost coverage, or have less income, and are worried about the possibility of a surprise bill.

Demand for veterinary services is typically cyclical: Pet owners spend more on medical care for dogs and cats when the economy is strong and they have more disposable income.

This economic downturn is different. Volume and revenue are up at animal hospitals and primary care offices. VetSuccess, which tracks financial data from 2,800 clinics, estimates that revenue last month was up 18 percent over last July.

Trupanion, a pet health insurer, announced in an earnings call this week that its second-quarter revenue was up 28 percent over last year. It has 14 percent more cat and dog members than it did at the start of the year (at a moment when 5.4 million American humans are estimated to have lost coverage). Some of those newly insured pets have names that fit the moment: Corona, Rona and Covid.

We were impacted by the 2008 recession, said Dr. Heather Loenser, senior veterinary officer for the American Animal Hospital Association. In March, if youd asked veterinarians where we thought wed be in the summer, we would not have thought wed have this surplus of pets and revenue.

Veterinarians attribute the increase in demand to one key factor that makes this recession different from others: It has forced millions more Americans to work from home.

Some are taking the opportunity to bring home new pets, with some shelters reportedly emptied out thanks to high demand. The national data, however, is a bit mixed: Shelter Animals Count, which tracks adoption data from nearly 1,500 animal shelters and rescue organizations, estimates that there have been fewer pet adoptions this year, largely because of fewer strays coming into their care.

Multiple veterinarians say they are seeing more puppies than normal, to the point they can no longer take on new clients.

Were having to limit who we are taking on as new clients because weve become overrun with requests, said Dr. Dirk Yelinek, president of the California Veterinary Medical Association, who practices at Redondo Shores Veterinary Center. Initially we tried to offer slots a week or two weeks out. Now theyre already full.

Americans who already had pets seem to have become more watchful of their animal companions during the long pandemic days at home together. Sometimes they notice important changes in the health of their cats and dogs. One emergency veterinarian reported a rise in cases of urinary obstructions among cats, which may be a sign of feline stress (possibly a result of humans hanging around more than the cat would like).

Other times veterinarians may see a case of, as Dr. Loenser describes it, staring at your pet syndrome: subtle differences that dont require medical care but catch the attention of a quarantined pet owner.

Its been really surprising, like what the heck? Why are we all so swamped? said Dr. Monica Mansfield, a veterinarian in Medway, Mass. In general, Im wondering if this might be related to an uptick in anxiety and people wanting to take care of health issues they can control.

The wave of demand comes even as the work of providing veterinary care is taking longer, straining clinics resources. Veterinarians say curbside visits require more time, as they play phone tag with owners and have to develop new intake processes.

We found it impossible to keep up with curbside care with our normal time slots, Dr. Mansfield said. If it was usually a 15-minute appointment, were now blocking out 30 minutes. Thats one reason our bookings are now bumped out a couple of weeks.

Some veterinarians say they are also seeing slightly sicker dogs, which may be a result of owners putting off care at the beginning of the pandemic. A few serious conditions may also be on the rise: BluePearl, which operates 90 pet hospitals across the country, has seen a 70 percent increase in hospitalizations for parvovirus, a potentially deadly ailment that most commonly strikes unvaccinated puppies.

We think owners earlier in the pandemic maybe didnt want to go out and see a veterinarian or maybe couldnt afford to, said Dr. James Barr, BluePearls chief medical officer. We think that probably resulted in fewer dogs getting vaccinated.

Dr. Barr said his hospitals were now seeing volume that was double digits higher than normal times.

Veterinarians operating at or over capacity have put a strain on the animal emergency rooms, which typically are open 24 hours and now appear to be handling the overflow from overwhelmed clinics.

When I take a call in our emergency room, owners are saying were often the third veterinary practice theyve called trying to get an appointment, said Dr. Armelle de Laforcade, an associate professor of clinical sciences at Tufts Universitys Cummings School of Veterinary Medicine.

Dr. de Laforcade practices emergency and critical care medicine at the universitys animal hospitals, which used to be able to see all patients turning up for appointments. Since the start of the pandemic, the hospitals have sometimes had to go on diversion, telling owners that theyre too full to accept more patients and directing them to clinics nearby.

Several times a week were having to say: Our case load is extremely high and we need to divert for a little while, Dr. de Laforcade said. Its more common than we would like.

Like other clinics, Tufts has had to hire new employees just to pick up the phone. Its part of adjusting to the new normal of operating in a pandemic and, as a veterinary teaching hospital, training the next generation of veterinarians at the same time.

Weve invested in cameras where you can watch operations when youre not in the room, Dr. de Laforcade said. Weve had to find a way to creatively deliver clinical education remotely.

See original here:
A Rare Economic Bright Spot in the U.S. Health System: The Vets Office - The New York Times

Read More...

What does the COVID-19 summer surge mean for your cats and dogs? – Science Magazine

August 15th, 2020 9:51 am

An employee takes a cats temperature at a cat caf in Bangkok.

By David GrimmAug. 14, 2020 , 4:00 PM

Sciences COVID-19 reporting is supported by the Pulitzer Center and the Heising-Simons Foundation.

Last month, the first U.S. dog to definitively test positive for COVID-19 died in New York City. The caninea German shepherd named Buddylikely had lymphoma, but the case served as a reminder that pets, too, are at risk.

Now, COVID-19 cases are surging in some areas of the United States, including in places that had largely escaped the virus in the spring, and some countries around the world are grappling with renewed outbreaks. People are also wondering and worrying about their pets.

Scientists are, too. It remains unclear, for example, how often cats and dogs become infected with the virus, what their symptoms are, and how likely they are to pass it along to other animals, including us. Yet veterinarians are hard on the case, and a handful of studies are starting to provide some answers. Experts have some concrete advice based on what we know so far.

Federal health agencies and veterinary experts have said since the beginning of the pandemic that pets are unlikely to pose a significant risk to people. Hard evidence from controlled studies for this assertion was lackingand still isbut everything scientists have seen so far suggests cats and dogs are highly unlikely to pass SARS-CoV-2 to humans. Theres a lot greater risk of going to the grocery store than hanging out with your own animal, says Scott Weese, a veterinarian at the University of Guelphs Ontario Veterinary College who specializes in emerging infectious diseases and who has dissected nearly every study on COVID-19 and pets on his blog.

Indeed, pets are much more likely to get the virus from humans than the other way around. Almost all pets that have tested positive have been in contact with infected humans, says Jane Sykes, chief veterinary medical officer at the University of California, Davis, and a founder of the International Society for Companion Animal Infectious Diseases, which is providing COVID-19 information to both pet owners and veterinarians. A genetic study of the viral sequences in the first two dogs known to have COVID-19 indicates they caught it from their owners. Even tigers and lions infected at New York Citys Bronx Zoo in April appear to have contracted the virus from humans.

But some researchers caution that this finding may be due in part to limited testing: Most of the pets that have been evaluated got the tests because they lived with humans who had already tested positive. Its a stacked deck, says Shelley Rankin, a microbiologist at the University of Pennsylvania School of Veterinary Medicine, whose lab is part of the U.S. Food and Drug Administrations Veterinary Laboratory Investigation and Response Network.

Still, most researchers think pets pose little risk to peopleand to other pets as well. A few studies have shown that cats can transmit SARS-CoV-2 to other cats, but all were conducted in an artificial laboratory setting. And, like many COVID-19 studies in humans, most studies are preprints that have yet to be published in peer-reviewed journals. Whats more, Sykes notes there have been multiple reports of households where one pet tested positive and others didnt. Everything weve learned so far suggests that its unlikely that pets are a significant source of transmission, she says.

Because pet testing remains rare, its unclear how many cats and dogs have been infected with SARS-CoV-2. A serological preprint published last month indicated that 3% to 4% of cats and dogs in Italy had been exposed to the virus at the height of the pandemic therecomparable to the rate among people.

A girl and her dog don masks in Regensburg, Germany.

But even if the numbers are really that high, there hasnt been a concomitant uptick in symptoms. The Seattle-based Trupanion, which provides health insurance for more than half a million dogs and cats in North America and Australia, says it has not seen an increase in respiratory claimsor any other type of health claimsince the pandemic began. No big trends are jumping out, says Mary Rothlisberger, the companys vice president of analytics, even when she looked at pandemic hot spots. Two recent studies have also shown that cats, at least, areunlikely toexhibit symptoms. My gut sense is that [the disease is] much more minor than were seeing in people, Sykes says.

That could meanpets are silent transmitters of the virus, as some scientists have suggested, but so far theres no direct evidence for this.

Several pet tests are available, but they arent widely used because the priority has been on human testing. Agencies like the United States Department of Agriculture havecautioned against routine testingof cats and dogs.

Even if your pet does test positive, Weese says, What are you going to do with the results? If your dog or cat has COVID-19, its probably because you do too, he says. It doesnt change anything for the pet or the family. And because there arent any drugs for the disease, he says, We wouldnt prescribe anything for the pet.

Whether it comes to taking your dog to a dog park or petting an outdoor cat, thestandard advice still holds: Wear a mask, wash your hands, and social distance. If you are not taking precautions you are putting both yourself and your animal at risk, Rankin says. But, she says, If you are a responsible pet owner, then it is probably safe to say that your animals risk [of infection] is lower than yours.

Weese agrees that people should be more concerned about other humans than about pets. The risk from people present at dog parks or vet clinics is much higher than the risk from dogs at those locations, he says.

Researchers are just beginning to understand how companion animals play into the pandemic. The pet studies so far are all part of a puzzle were still trying to put together, Sykes says.

And theyre preliminary. Almost every preprint I have seen is flawed in some way, says Rankin, who dings small sample sizes, incomplete data, and a lack of vigorous testing. That doesnt necessarily invalidate the results, but she and others would like to see more robust studies.

Sykes and Weese, for example, want more research done in the home. That could give scientists a better sense of how likely pets are to transmit the virus to other pets, how long pets remain contagious, and whatif anyclinical signs of COVID-19 show up.

Rankin is part of a project to do what she calls full-on epidemiology of the complete medical backgrounds, including any COVID-19 cases, of 2000 pets that have been seen at her vet school for various reasons, or just for routine checkups. The hope is that such an approach will weed out some of the biases of previous studiessuch as those that only looked at pets in COVID-19positive homesand get a better sense of the true risk factors for the disease.

Sykes and Weese are involved in similar endeavors. Weese also hopes to investigate whether pets, especially feral and outdoor cats, pose a risk to wildlife. If we want to eradicate this virus, he says, we need to know everywhere it might be.

Other researchers are exploring whether drugs that treat other coronaviruses in catscould also combat COVID-19in both pets and people. Answering these questions isnt just important for companion animal health, Sykes says. It could help us, too.

Read the original:
What does the COVID-19 summer surge mean for your cats and dogs? - Science Magazine

Read More...

Virtual Celebration to Honor Distinguished Alumni and Outstanding Teacher Award Recipients – Purdue Veterinary News

August 15th, 2020 9:51 am

Friday, August 14, 2020

A longstanding Purdue University College of Veterinary Medicine tradition of recognizing distinguished alumni and outstanding faculty during the annual Purdue Veterinary Conference will continue in a virtual format this year. The entire conference September 22-25 will be conducted virtually, enabling attendees to join in on conference sessions and special activities from their home or office. The annual Awards Celebration will include the presentation of two Distinguished Alumni Awards and the Raymond E. Plue Outstanding Teacher Award on Wednesday, September 23, at 5:00 p.m. (EDT).

The two Distinguished Alumni Award winners are Dr. Tom Troxel, of the DVM Class of 1981, and Dr. Debbie White, of the DVM Class of 1994. Dr. Tom, as he is called by his clients in Northwestern Indiana, has become highly respected for his work as a veterinarian, dairy farmer, teacher, and lay minister. His reputation reaches far around the world with partnerships in Eastern Europe and Haiti related to dairy production and education. Students have traveled from around the world to receive hands-on instruction from Dr. Tom, who also has mentored Purdue veterinary students during their externships. Known as a compassionate and knowledgeable clinician, Dr. Tom is perhaps most recognized for his genuine interest in supporting herd health as well as profitability for farmers.

Dr. Debbie White is well known to fans of her talk-show Animal Radio as a knowledgeable and vibrant veterinarian. She has contributed admirably to the veterinary profession throughout her career. Currently serving as vice president of the Western Veterinary Conference (now known as the Viticus Group), Dr. White has held multiple board positions with professional organizations. A skilled clinician who owns several animal hospitals throughout the Las Vegas, Nev. area, she is a positive role model and ambassador for Purdue.

Another prestigious award to be presented at the Awards Celebration is the Raymond E. Plue Outstanding Teacher Award, which this year will go to Dr. Stephanie Thomovsky, clinical associate professor of veterinary neurology in the Department of Veterinary Clinical Sciences. To be considered for this honor, a faculty member must be nominated by veterinary alumni in the four most recent graduating classes. Award recipients are chosen for their teaching ability as well as their role in fostering interest in research. Hailing from Buffalo, N.Y., Dr. Thomovsky earned her DVM degree at Iowa State University and completed a neurology/neurosurgery internship before joining Purdue Veterinary Medicines residency program. She then served on the faculty at Washington State University before returning to Purdue to accept a faculty position in neurology and establish the Physical Rehabilitation service in the Purdue University Veterinary Hospital. Her nominator praised Dr. Thomovsky for her ability to simplify complex learning materials and inspire students.

Click here to register for the virtual Purdue Veterinary Conference, and plan to join in the Awards Celebration online Wednesday, September 23 at 5:00 p.m., to help honor Drs. Troxel, White, and Thomovsky, as well as several other faculty members who also will receive awards.

Writer(s): Susan Xioufaridou and Kevin Doerr | pvmnews@purdue.edu

Read more:
Virtual Celebration to Honor Distinguished Alumni and Outstanding Teacher Award Recipients - Purdue Veterinary News

Read More...

Dog that died at NCSU vet school tested positive for coronavirus – WRAL.com

August 15th, 2020 9:51 am

By Matthew Burns, WRAL.com senior producer/politics editor, & Leslie Moreno, WRAL multimedia journalist

Raleigh, N.C. State officials on Tuesday reported the first confirmed case of coronavirus in a dog that died last week at the North Carolina State University Veterinary Hospital.

The SARS-CoV-2 virus was confirmed by both the hospital lab and by the National Veterinary Services Laboratories. The dog's cause of death is still undetermined.

The dog was taken to N.C. State on Aug. 3 after showing signs of respiratory distress, officials said. The owner told staff at the veterinary hospital that a family member had previously tested positive for coronavirus.

"It would be a fair assumption that the virus came from the household to the pet, but that doesnt necessarily mean thats what caused the disease or thats what caused the death of this patient," said Dr. Steven Marks, associate dean and director of Veterinary Medical Services at N.C. State's College of Veterinary Medicine.

According to the Centers for Disease Control and Prevention and the U.S. Department of Agricultures Animal and Plant Health Inspection Service (APHIS), there is no evidence that pets play a significant role in spreading the virus.

"Dogs that you have seen throughout the U.S., and cats too that are positive, they had to have been exposed somewhere," State Public Health Veterinarian Dr. Carl Williams said. "The likelihood is, due to widespread community transmission among people, they are probably exposed to infected people, and thats how they have come in contact with the virus."

In April, a pug n Chapel Hill was believed to have tested positive for the virus in one of the first cases in the U.S. of a family pet with the virus. But further testing later showed that the dog likely never had the virus, although human members of the household did.

There is no indication at this time that dogs can transmit the virus to other animals, so there is no justification in taking measures against companion animals that may compromise their welfare, State Veterinarian Dr. Doug Meckes said in a statement.

Still, state and federal officials plan to evaluate other pets in the home of the dog that died to determine if pet-to-pet transmission may have occurred.

Only 13 other dogs nationwide have tested positive for coronavirus, according to APHIS, including a second one in North Carolina.

I think this is hopefully a rare event but certainly not something thats outside the realm of possibility," Williams said.

If pet owners are concerned about the health of their dog or cat, officials said, they should contact their veterinarian and discuss the pets symptoms before bringing them to a veterinary office.

The pet is a family member, and it scares me also if my daughter gets it, but its just part of what were facing right now," local pet owner Diana Salazar said.

Read the original here:
Dog that died at NCSU vet school tested positive for coronavirus - WRAL.com

Read More...

Helping Pets Have A Positive Transition After Quarantine – Texas A&M Today – Texas A&M University Today

August 15th, 2020 9:51 am

The most important step owners can take in preventing separation anxiety is to prepare early.

Getty Images

A silver lining to the stress of stay-at-home orders for many has been extra time spent with pets. Whether that means extra-long walks for dogs, chin scratches for cats or quality time and attention for all of the other critters, many of our furry friends have benefited from this pause in society.

Dr. Lori Teller, an associate professor in the Texas A&M University College of Veterinary Medicine & Biomedical Sciences, says pets that have grown used to having near-constant contact with their owner may experience separation anxiety when their owner returns to a more regular routine. Because of this, she recommends that owners prepare now for a return to work or school.

Before the pandemic, people would come and go and most animals were quite used to this. But now, owners have been at home for much of the day, and their pets are used to getting frequent walks or other types of attention. An abrupt change in the schedule can be very stressful for some animals, Teller said. It also is possible for a pet that has not had previous symptoms of separation anxiety to develop these symptoms as people return to work or school following stay-at-home orders.

Owners can help their pets adjust by leaving the house for short periods of time and monitoring the pets response, Teller said. An owner may need to set up the camera on a phone or tablet to record the pets response to his or her departure. If the animal seems fine, increase the amount of time away from home to determine if there will be problems.

Teller also recommends identifying high-value treats a pet enjoys, such as food puzzles or toys filled with frozen treats. If owners only provide these treats when they leave the house, the pet will associate good things with their departure and be less prone to anxiety. Owners should also make their departures as low-key as possible after giving their pet a special treat.

You can also leave on some music for the pet, she said. Studies have shown that dogs and cats like classical music and soft rock, and some dogs have a preference for reggae.

By beginning to match their quarantine routine with what owners expect their future schedule to look like, they can acclimate their animal to certain walk lengths, times and cuddling schedules before any big changes.

Teller also says that people who adopted a puppy or kitten during the pandemic should be extra mindful, as these pets have only ever lived in a household where humans are always around.

Dogs with separation anxiety may pace, pant, salivate, or bark or howl excessively. In more serious cases, a dog may become destructive and scratch or chew at doors or windows in an effort to escape, Teller said. Cats may groom excessively or stop urinating in the litter box.

The most important step owners can take in preventing separation anxiety is to prepare early. Even if a pet is only exhibiting mild signs of separation anxiety, their owner should reach out to a veterinarian to get help before a pet hurts themselves or damages their home.

For mild cases, veterinarians may recommend some of the dog or cat pheromones that promote calmness and relaxation, she said. There are also some nutraceuticals (a pharmaceutical alternative that claims psychological benefits) that help with calming and relaxation, as well as a variety of prescription medications that can help lessen anxiety.

A veterinarian can help you determine what is best for your pet and how you can best help them adjust to time alone. They may also refer you to a veterinary behavior specialist for more severe cases.

If separation anxiety is allowed to go unchecked, it can be that much more difficult to treat, Teller said. Reach out to your veterinarian as soon as you suspect a problem. Issues generally have a good prognosis when intervention happens early.

Read more:
Helping Pets Have A Positive Transition After Quarantine - Texas A&M Today - Texas A&M University Today

Read More...

Vetschool Tails: The beat goes on for long-time four-legged Spartan – MSUToday

August 15th, 2020 9:51 am

Lola, an 8-year-old pit bull terrier, presented to the Michigan State University Emergency and Critical Care Medicine Service on Friday, April 17, 2020 for tri-cavitary effusion, or fluid within the abdominal, chest, and pericardial cavities. Her owner noted that she had been lethargic and bloated for several days. Lolas additional medical history includes a long relationship with the MSU Orthopedic Surgery and Rehabilitation services for knee injuries.

On presentation, Lola was quiet, alert and responsive with pink mucus membranes. Her heart and lungs were muffled on auscultation, though her heart rate was slightly faster than normal, and she demonstrated effort while breathing. She had a marked fluid wave, consistent with abdominal effusion. Pulse oximetry was 91% (most patients are >98%). Both abdominal and thoracic FAST scan (focused assessment with sonography for trauma) were positive for fluid throughout the abdomen, chest, and around the heart.

Approximately one hour later, Lolas mentation became dull and her mucous membranes were cyanotic (blue). A total of 880 mL of transudate (blood-tinged clear fluid) was removed from the area around her heart and lungs; no abnormal cells were noted by the pathologist. An echocardiogram was performed which revealed an at least 2.5 x 4.5 cm tumor over the left atrial body, compressing the heart.

Lola continued to develop fluid around the heart which required removal and placement of a pericardial catheter starting the next morning, Saturday, April 18.

For the full story, visit the College of Veterinary Medicine.

See the rest here:
Vetschool Tails: The beat goes on for long-time four-legged Spartan - MSUToday

Read More...

Page 422«..1020..421422423424..430440..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick